カテゴリ： MarketLine, アメリカ, 企業調査

Split Rock Partners, LLC：企業の戦略・SWOT・財務情報

◆英語タイトル：Split Rock Partners, LLC - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C13268
◆発行会社（調査会社）：MarketLine
◆発行日：2019年2月
◆ページ数：29
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Split Rock Partners, LLC – Strategy, SWOT and Corporate Finance Report
Summary

Split Rock Partners, LLC – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Split Rock Partners, LLC (Split Rock Partners) is a venture capital firm with an investment portfolio in healthcare, software and Internet services. The company offers investment solutions for analytics and big data, cloud services, enterprise software and infrastructure, marketing technologies, and healthcare companies It offers investment solutions on the basis of management team, business model, market size and competitive position of the company. Split Rock Partners is headquartered in Minneapolis, Minnesota, the US.

Scope

- Detailed information on Split Rock Partners, LLC required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Split Rock Partners, LLC in the form of a SWOT analysis
- An in-depth view of the business model of Split Rock Partners, LLC including a breakdown and examination of key business segments
- Intelligence on Split Rock Partners, LLC’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Split Rock Partners, LLC, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Split Rock Partners, LLC and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Split Rock Partners, LLC as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Split Rock Partners, LLC’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Split Rock Partners, LLC: Company Overview
Split Rock Partners, LLC: Overview and Key Facts
Split Rock Partners, LLC: Overview
Split Rock Partners, LLC: Key Facts
Split Rock Partners, LLC: Key Employees
Split Rock Partners, LLC: Key Employee Biographies
Split Rock Partners, LLC: Major Products and Services
Split Rock Partners, LLC: Company History
Split Rock Partners, LLC: Management Statement
Split Rock Partners, LLC: Locations and Subsidiaries
Split Rock Partners, LLC: Key Competitors
Split Rock Partners, LLC: Company Analysis
Split Rock Partners, LLC: Business Description
Split Rock Partners, LLC: SWOT Analysis
Split Rock Partners, LLC: SWOT Overview
Split Rock Partners, LLC: Strengths
Split Rock Partners, LLC: Weaknesses
Split Rock Partners, LLC: Opportunities
Split Rock Partners, LLC: Threats
Split Rock Partners, LLC: Corporate Financial Deals Activity
Split Rock Partners, LLC: Financial Deals Overview
Split Rock Partners, LLC: Targets and Partners
Split Rock Partners, LLC: Top Deals 2015 – 2019YTD*
Split Rock Partners, LLC: Mergers and Acquisitions
Split Rock Partners, LLC: Corporate Venturing
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Split Rock Partners, LLC: Key Facts
Table 2: Split Rock Partners, LLC: Key Employees
Table 3: Split Rock Partners, LLC: Company History
Table 4: Split Rock Partners, LLC: Locations and Subsidiaries
Table 5: Split Rock Partners, LLC: Key Competitors
Table 6: Split Rock Partners, LLC: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Split Rock Partners, LLC: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: Split Rock Partners, LLC: M&A Average Deal Size - Value (US$m)
Table 9: Split Rock Partners, LLC: Targets and Partners
Table 10: Split Rock Partners, LLC: Top Deals 2015 - 2019YTD*
Table 11: Split Rock Partners, LLC: M&A Volume and Value Trend (2015 - YTD*2019)
Table 12: Split Rock Partners, LLC: M&A Activity by Geography (2015 - YTD*2019)
Table 13: Split Rock Partners, LLC: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Table 14: Split Rock Partners, LLC: Corporate Venturing by Geography (2015 - YTD*2019)

List of Figures
Figure 1: Split Rock Partners, LLC: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Split Rock Partners, LLC: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 3: Split Rock Partners, LLC: M&A Average Deal Size - Value (US$m)
Figure 4: Split Rock Partners, LLC: M&A Volume and Value Trend (2015 - YTD*2019)
Figure 5: Split Rock Partners, LLC: M&A Activity by Geography (2015 - YTD*2019)
Figure 6: Split Rock Partners, LLC: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Figure 7: Split Rock Partners, LLC: Corporate Venturing by Geography (2015 - YTD*2019)

★海外企業調査レポート[Split Rock Partners, LLC：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Micell Technologies Inc：医療機器：M&Aディール及び事業提携情報
    Summary Micell Technologies Inc (Micell) is a medical device company that develops drug delivery systems for the treatment of cardiovascular diseases. The company provides product such as MiStent sirolimus eluting absorbable polymer coronary stent system, a drug-eluting stent that is designed to opt …
  • ION Geophysical Corp (IO)：企業の財務・戦略的SWOT分析
    ION Geophysical Corp (IO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Fenner PLC (FENR)：企業の財務・戦略的SWOT分析
    Summary Fenner PLC (Fenner) a subsidiary of Michelin SCA, is a provider of reinforced polymer technology. The company operates in the areas of advanced engineered products and engineered conveyor solutions. Its product portfolio includes heavyweight conveyor belt, high performance polymer components …
  • T&D Holdings, Inc.：企業の戦略・SWOT・財務分析
    T&D Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary T&D Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Luminex Corp (LMNX)：企業の財務・戦略的SWOT分析
    Luminex Corp (LMNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Okamura Corporation：企業の戦略・SWOT・財務情報
    Okamura Corporation - Strategy, SWOT and Corporate Finance Report Summary Okamura Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Halozyme Therapeutics Inc (HALO)：医療機器：M&Aディール及び事業提携情報
    Summary Halozyme Therapeutics Inc (Halozyme) is a biotechnology company that develops and commercializes novel recombinant human enzymes to provide innovative products for cancer, dermatology, diabetes and drug delivery markets. The company’s marketed product, Hylenex is an agent for drug and fluid …
  • Babcock International Group Plc：企業のM&A・事業提携・投資動向
    Babcock International Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Babcock International Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Coresa Sa
    Coresa Sa - Strategy, SWOT and Corporate Finance Report Summary Coresa Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Green’s General Foods Pty Ltd：企業の戦略・SWOT・財務情報
    Green’s General Foods Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Green’s General Foods Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • ERI Bancaire SA：企業の戦略的SWOT分析
    ERI Bancaire SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • SNC-Lavalin Group Inc.：企業の戦略・SWOT・財務情報
    SNC-Lavalin Group Inc. - Strategy, SWOT and Corporate Finance Report Summary SNC-Lavalin Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Bankers Petroleum Ltd：企業の戦略的SWOT分析
    Bankers Petroleum Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Ayala Land Inc：戦略・SWOT・企業財務分析
    Ayala Land Inc - Strategy, SWOT and Corporate Finance Report Summary Ayala Land Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Accugenomics Inc-医療機器分野：企業M&A・提携分析
    Summary Accugenomics Inc (Accugenomics) is a provider of molecular diagnostics for cancer. The company develops and markets gene expression tests to diagnose and monitor cancer treatment. It offers gene expression tests including lung cancer risk test, standardized BCR-ABL molecular diagnostics test …
  • Ramba Energy Ltd (R14)：石油・ガス：M&Aディール及び事業提携情報
    Summary Ramba Energy Ltd (Ramba Energy), a subsidiary of Redmount Holdings Ltd, is an oil and gas company that offers exploration and production of oil and gas properties in Indonesia. The company provides services such as inbound and outbound transportation activities, seaport and airport cargo han …
  • Globo Comunicacao e Participacoes S.A.：企業の戦略的SWOT分析
    Globo Comunicacao e Participacoes S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Sberbank Rossii：企業の戦略・SWOT・財務情報
    Sberbank Rossii - Strategy, SWOT and Corporate Finance Report Summary Sberbank Rossii - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Adamas Pharmaceuticals Inc (ADMS)：製薬・医療：M&Aディール及び事業提携情報
    Summary Adamas Pharmaceuticals Inc (Adamas Pharmaceuticals) is a pharmaceutical company that develops and commercializes therapeutics for chronic disorders of the central nervous system. The company's Gocovri, formerly ADS-5102, is an amantadine extended-release (XR) formulation for the treatment fo …
  • Synmosa Biopharma Corp (4114)：製薬・医療：M&Aディール及び事業提携情報
    Summary Synmosa Biopharma Corp (Synmosa) is a pharmaceutical company that manufactures, markets and distributes generic medicines. The company produces non-pharmaceutical products such as cosmeceutical and nutrition products, and food supplements in effervescent tablet and granule forms. It offers p …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆